Calendula officinalis, this product is a traditional Chinese medicine extract preparation, its dosage forms are tablets, injections, drops, etc.. It has the effect of dilating cerebral blood vessels and anti-blood clotting. It is clinically used to treat cerebral blood supply deficiency, sequelae due to cerebral hemorrhage, hyperviscosity, cerebral thrombosis, coronary heart disease, angina pectoris and other diseases.
Drug name: Lanosterol
Foreign name: Breviscapine
Alias: Breviscapine, Breviscapine, Breviscapine, Breviscapine, Breviscapine, Breviscapine, Breviscapine, Breviscapine, Breviscapine
Main indications: The effect of dilation of cerebral blood vessels, can reduce cerebrovascular resistance, etc.
Contraindications: Forbidden to be used in the acute phase of cerebral hemorrhage or in patients with bleeding tendency.
Dosage form: tablet athletes caution is whether the main properties of the inclusion of medical insurance is yellow powder, hygroscopicity, odorless

English name: (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
English Alias: Breviscapin; 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-chromen-7-yl |A-d-glucopyranosiduronic acid
Scutellarein-7beta-D-glucuronoside; Scutellarein-7beta-D-glucuronide; Breviscapine
CAS No.: 116122-36-2
Molecular formula: C42H36O23
Molecular weight: 908.72100
Precise mass: 908.16500
PSA: 394.47000
Physical and chemical properties
Density: 1.81g/cm3
Boiling point: 891.6ºC at 760mmHg
Flash point: 314.9ºC
Vapor pressure: 3.91E-34mmHg at 25°C
Refractive index: 1.763

Indications
Calendula officinalis has the effect of dilating cerebral blood vessels, reducing cerebral vascular resistance, increasing cerebral blood flow, improving microcirculation, and has an anti-platelet aggregation effect. Therefore, it can be used for the treatment of ischemic cerebrovascular diseases, such as cerebral thrombosis, cerebral embolism, cerebral hemorrhage and other sequelae of paralysis patients, with better efficacy, for the duration of the disease within 6 months than those who are more than 6 months.

Contraindications
Forbidden to be used in patients in the acute stage of cerebral hemorrhage or those with bleeding tendency.

Characteristic
It is a yellow powder with some hygroscopicity; odorless. Tasteless or slightly salty.

Pharmacological effects
It is an oral tablet extracted from the whole plant of Calendula officinalis on the Yunnan-Guizhou plateau, which is refined from the flavonoid active ingredient calendula. It mainly has the effects of anti-coagulation, anti-thrombosis, improving blood rheology and microcirculation, increasing cerebral blood flow, anti-myocardial ischemia and improving the body's ability to resist hypoxia.

Company Introduction
Address: Room 202, Building B8, Huanchuang Enterprise Square, Lugu Street, Yuelu District, Changsha City, Hunan Province
Website: http://www.staherb.cn/
Business scope: Biotechnology, research and development of plant extracts (can be used in the field of pharmaceutical and health products, cosmetics, feed additives and biological pesticide production and development)
Main products: Eucommia extract - chlorogenic acid (5%-98%), ursolic acid (25%-98%), corosolic acid (1%-98%), bitter amygdalin (50%-98%), epimedoside (10%-98%) and other standardized high-purity plant extracts.

If you wanna know more about us, please feel free to contact me at:
Whatsapp: +86 13548561509
Email: staherb18@staherb.cn
or you can send me online message if it's convenient for you.
We look forward to cooperating with you!